Search

everythinglearnresearchcommunity

for

Search:↓

Certain variations of the HDAC9 gene can increase or decrease stroke risk in the Chinese population.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Different sheep breeds share similar genetic factors affecting wool fineness.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Using microneedling with platelet-rich plasma is more effective and just as safe as microneedling alone for treating acne scars.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Baldness may lower the risk of testicular cancer.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

Botulinum Toxin can improve hair growth in androgenetic alopecia, but more research is needed.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Botulinum toxin Type A helps reduce hypertrophic scars and is generally safe.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata may increase the risk of cardiovascular disease.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Policosanol biorefining shows promise for heart health, needing better academic-industrial collaboration.